Whole-Blood Gene Expression in Pulmonary Nontuberculous Mycobacterial Infection
Steven A Cowman1,2, Joseph Jacob1,3, David M Hansell1,3
11 National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Abstract:
The factors predisposing toward the development of pulmonary nontuberculous mycobacterial (pNTM) disease and influencing disease progression remain unclear. Impaired immune responses have been reported in individuals with pNTM disease, but data are limited and inconsistent. In this study, we sought to use gene expression profiling to examine the host response to pNTM disease. Microarray analysis of whole-blood gene expression was performed on 25 subjects with pNTM disease and 27 uninfected control subjects with respiratory disease. Gene expression results were compared with phenotypic variables and survival data. Compared with uninfected control subjects, pNTM disease was associated with downregulation of 213 transcripts enriched for terms related to T cell signaling, including IFNG. Reduced IFNG expression was associated with more severe computed tomography changes and impaired lung function. Mortality was associated with the expression of transcripts related to the innate immune response and inflammation, whereas transcripts related to T and B cell function were associated with improved survival. These findings suggest that pNTM disease is associated with an aberrant immune response, which may reflect an underlying propensity to infection or result from NTM infection itself. There were important differences in the immune response associated with survival and mortality in pNTM disease.
Insights
Pulmonary nontuberculous mycobacterial (pNTM) disease involves an aberrant immune response, with reduced T cell signaling linked to severity. Immune cell function impacts survival outcomes in patients with pNTM disease.
Area of Science:
- Immunology
- Pulmonary Medicine
- Genomics
Background:
- Factors influencing pulmonary nontuberculous mycobacterial (pNTM) disease development and progression are not fully understood.
- Existing data on impaired immune responses in pNTM disease are limited and inconsistent.
Purpose of the Study:
- To investigate the host immune response in pNTM disease using gene expression profiling.
- To correlate gene expression patterns with clinical phenotypes and survival data.
Main Methods:
- Microarray analysis of whole-blood gene expression in 25 pNTM disease patients and 27 controls.
- Comparison of gene expression data with computed tomography (CT) findings, lung function, and survival.
Main Results:
- pNTM disease showed downregulation of transcripts related to T cell signaling, including interferon-gamma (IFNG).
- Reduced IFNG expression correlated with more severe CT changes and poorer lung function.
- Distinct immune response profiles were associated with survival (T and B cell function) and mortality (innate immunity and inflammation).
Conclusions:
- pNTM disease is characterized by an aberrant immune response, potentially predisposing to infection or resulting from it.
- Immune response pathways significantly differ between survivors and non-survivors of pNTM disease.
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pneumonia II: Pathophysiology


